EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis

Jinghui Gao, Elijah Sterling, Rachel Hankin iD, Aria Sikal, Yao Yao iD

Biomolecules · 22.07.2024 · 14 (7) · 878

DOI: 10.3390/biom14070878 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 22.07.2024. Verfasst von Jinghui Gao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Regenerative Bioscience Center, Department of Animal and Dairy Science, College of Agricultural and Environmental Science, University of Georgia, Ath…. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Muscle, Skeletal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, Department of Defense Congressionally Directed Medical Research Programs Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award, University of Georgia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyotrophic lateral sclerosis (ALS) is a complex neuromuscular disease characterized by progressive motor neuron degeneration, neuromuscular junction dismantling, and muscle wasting. The pathological and therapeutic studies of ALS have long been neurocentric. However, recent insights have highlighted the significance of peripheral tissue, particularly skeletal muscle, in disease pathology and treatment. This is evidenced by restricted ALS-like muscle atrophy, which can retrogradely induce neuromuscular junction and motor neuron degeneration. Moreover, therapeutics targeting skeletal muscles can effectively decelerate disease progression by modulating muscle satellite cells for muscle repair, suppressing inflammation, and promoting the recovery or regeneration of the neuromuscular junction. This review summarizes and discusses therapeutic strategies targeting skeletal muscles for ALS treatment. It aims to provide a comprehensive reference for the development of novel therapeutics targeting skeletal muscles, potentially ameliorating the progression of ALS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisMuscle, SkeletalHumansAnimalsNeuromuscular JunctionMotor Neurons

Stichwörter der Autor:innen

amyotrophic lateral sclerosis (ALS)inflammationmuscle satellite cells (MuSCs)neuromuscular junction (NMJ)skeletal muscle

Autor:innen und Institutionen

  • Regenerative Bioscience Center, Department of Animal and Dairy Science, College of Agricultural and Environmental Science, University of Georgia, Athens, GA 30602, USA.

ORCID-Profile: Rachel Hankin, Yao Yao

Förderung

  • United States Department of Defense
  • Department of Defense Congressionally Directed Medical Research Programs Amyotrophic Lateral Sclerosis Research Program Therapeutic Idea Award
  • University of Georgia

Zitieren

APA

Gao, J., Sterling, E., Hankin, R., Sikal, A., & Yao, Y. (2024). Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis. Biomolecules, 14(7), 878. https://doi.org/10.3390/biom14070878

Vancouver

Gao J, Sterling E, Hankin R, Sikal A, Yao Y. Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis. Biomolecules. 2024;14(7):878. doi:10.3390/biom14070878

BibTeX
@article{Gao2024,
  author = {Gao, Jinghui and Sterling, Elijah and Hankin, Rachel and Sikal, Aria and Yao, Yao},
  title = {Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {7},
  pages = {878},
  doi = {10.3390/biom14070878}
}
Kostenlos starten →